Reply to Medsafe from NZDSOS

Name: Reply to Medsafe from NZDSOS
Rating: 1.4 (655 reviews)

July 6, 2021February 4, 2022 Reading Time: 1 minute

Our letter to Medsafe requesting approval for Ivermectin and pausing of the vaccine rollout to allow investigation of adverse events.